Abstract
Omalizumab is currently used in severe asthma and has been tried in other allergic disorders. The authors report two patients with multiple food allergies and eosinophilic esophagitis on a very restrictive diet who have been treated with omalizumab, in order to improve food intolerance—the major distressing factor in their lives. The patients significantly improved in the reported symptoms. However, no improvement was seen regarding esophageal endoscopy and histology. Given the poor histological and endoscopy response, eosinophilic esophagitis persistence is unlikely to be IgE dependent. Omalizumab may improve the quality of life of patients with severe food allergy by improving symptoms, but it does not appear to change endoscopic and histological features of eosinophilic esophagitis in a short follow-up.
Similar content being viewed by others
References
Alpan O (2009) Identifying responders to Xolair (omalizumab) using eosinophilic esophagitis as a disease model. ClinicalTrials.gov identifier: NCT01040598. Available via http://clinicaltrials.gov. Accessed 2 April 2011
Fang JC (2005) A pilot study of the treatment of eosinophilic esophagitis with omalizumab. ClinicalTrials.gov identifier: NCT00123630. Available via http://clinicaltrials.gov. Accessed 2 April 2011
Menzella F, Facciolongo N, Castagnetti C, Simonazzi A, Zucchi L (2009) Omalizumab: when the non-responder is a late-responder. Eur Ann Allergy Clin Immunol 41(5):155–9
Rafi A, Do LT, Katz R, Sheinkopf LE, Simons CW, Klaustermeyer W (2010) Effects of omalizumab in patients with food allergy. Allergy Asthma Proc 31(1):76–83
Stein ML, Collins MH, Villanueva JM, Kushner JP, Putnam PE, Buckmeier BK, Filipovich AH, Assa'ad AH, Rothenberg ME (2006) Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 118(6):1312–9
Stone KD, Prussin C (2008) Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases. Clin Exp Allergy 38(12):1858–65
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rocha, R., Vitor, A.B., Trindade, E. et al. Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr 170, 1471–1474 (2011). https://doi.org/10.1007/s00431-011-1540-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-011-1540-4